• Prescribing Information
    RYBREVANT FASPRO™ Prescribing InformationRYBREVANT® Prescribing InformationLAZCLUZE® Prescribing InformationRYBREVANT® Información
    de Prescripción    LAZCLUZE® Información
    de Prescripción    RYBREVANT® 處方信息LAZCLUZE® 處方信息
  • Important Safety Information
  • Medical Information
  • For US Patients
  • Register for Updates
  • Find a J&J Specialist
  • This site is intended for
    US healthcare professionals.
  • For US Healthcare Professionals
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) logo, home
  • Unmet Needs
  • Mechanism of Action
  • Clinical Trial Results
  • Dosage & Administration
  • Therapy Management
  • Resources
    • For APPs & Nurses
    • Prescribing Information
      RYBREVANT FASPRO™ Prescribing InformationRYBREVANT® Prescribing InformationLAZCLUZE® Prescribing InformationRYBREVANT® Información
      de Prescripción      LAZCLUZE® Información
      de Prescripción      RYBREVANT® 處方信息LAZCLUZE® 處方信息
    • Important Safety Information
    • Medical Information
    • For US Patients
    • Register for Updates
    • Find a J&J Specialist
    • This site is intended for
      US healthcare professionals.
For APPs & Nurses

SIGN UP FOR UPDATES